# A Study in Normal Healthy People, Testing Different Versions of a Pill That Will be Used to Treat Rheumatoid Arthritis.

> **NCT00838058** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 11 (actual)

## Conditions studied

- Rheumatoid Arthritis
- Healthy Volunteers

## Interventions

- **DRUG:** CE-224,535
- **DRUG:** CE-224,535
- **DRUG:** CE-224,535
- **DRUG:** CE-224,535
- **DRUG:** CE-224,535
- **DRUG:** CE-224,535
- **DRUG:** CE 224,535
- **DRUG:** CE 224,535

## Key facts

- **NCT ID:** NCT00838058
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2009-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00838058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00838058, "A Study in Normal Healthy People, Testing Different Versions of a Pill That Will be Used to Treat Rheumatoid Arthritis.". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00838058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*